http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103524349-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C68-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C68-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-265 |
filingDate | 2013-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103524349-B |
titleOfInvention | CA-4 carbonates derivative, its preparation method, pharmaceutical composition and medicinal use |
abstract | The present invention relates to CA-4 carbonates derivative, its preparation method, pharmaceutical composition and medicinal use.Described CA-4 carbonates derivative is the compound with general formula 6, is that phenolic hydroxyl group in CA-4 molecule is contained the CA-4 ester derivative of alkyl ester group by a class side chain obtained after chloro-formic ester esterification.The present invention also provides preparation method and the pharmaceutical composition of this CA-4 carbonates derivative.Described CA-4 carbonates derivative for the preparation of antitumor drug, the application particularly in anti-human mammary cancer or leukemia medicament. |
priorityDate | 2013-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.